Alongside the FDA’s orphan drug designation in the U.S., the European Commission’s orphan medicinal product designation for mitapivat underscores the urgent need for novel therapies for sickle cell ...

Vandria SA, a company at the vanguard of mitochondrial therapeutics developing first-in-class small molecule mitophagy inducers, today announces that the first subjects have been dosed in its first-in ...

The U.S. International Trade Commission said on Tuesday that smartphones made by Lenovo's Motorola Mobility infringe patents ...

Purdue Polytechnic Institute has unveiled a solar-powered, simplified light system that it says will automatically indicate ...

The Apple modem fears are overblown, and the company has significant upside catalysts in the future. Click here to read an ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's disease Primary endpoints met in ulcerative colitis (UC) and Crohn's disease (CD), the most ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the ...

Bisman Kaur of Remfry & Sagar says recent reports indicate the development of India’s intellectual property culture is ...

Quinn Emanuel Urquhart & Sullivan has promoted 11 attorneys to its partner ranks, the firm announced Monday. About half of ...

Winners of UTSA’s annual Innovation Awards were recently announced, in recognition of their substantial contributions to the ...